← Open Payments lookup

ROBERT SCHNACKENBERG: Open Payments

NPI 1548240484 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,452 in 88 payments from 14 companies in 2025. Trend: 2023 $957 · 2024 $1,546 · 2025 $1,452

Food & beverage: $1,452
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$321
ABBVIE INC.33$277
Bausch Health US, LLC9$197
Neurocrine BioSciences, Inc.5$143
Otsuka America Pharmaceutical, Inc.7$125
Alkermes, Inc.5$105
Lundbeck LLC4$79
Noven Therapeutics, LLC4$64
Axsome Therapeutics, Inc.2$35
Supernus Pharmaceuticals, Inc.1$26

Products named: CAPLYTA, VRAYLAR, REXULTI, APLENZIN, INGREZZA, LYBALVI, Xelstrym, ARISTADA.

Industry payments across SC — which companies pay providers there.